179 related articles for article (PubMed ID: 16269182)
1. Acute fulminant hepatitis B in a patient with diabetic nephropathy treated successfully with concomitant lamivudine and molecular adsorbents recirculating system.
Tsai SH; Chang HM; Hsieh CB; Chao YC; Hsieh TY
J Infect; 2006 Jul; 53(1):e19-23. PubMed ID: 16269182
[TBL] [Abstract][Full Text] [Related]
2. Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B-associated fulminant hepatic failure.
Tsai MH; Chen YC; Wu CS; Ho YP; Fang JT; Lien JM; Yang C; Chu YY; Liu NJ; Lin CH; Chiu CT; Chen PC
Int J Clin Pract; 2005 Nov; 59(11):1289-94. PubMed ID: 16236082
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP
J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192
[TBL] [Abstract][Full Text] [Related]
4. Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease.
Wong VW; Chan HL
J Gastroenterol Hepatol; 2009 Jul; 24(7):1179-86. PubMed ID: 19682192
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
[TBL] [Abstract][Full Text] [Related]
6. [Lamivudine therapy in patients with severe acute hepatitis B].
Roznovský L; Orságová I; Kloudová A; Mrázek J
Klin Mikrobiol Infekc Lek; 2007 Apr; 13(2):59-65. PubMed ID: 17599294
[TBL] [Abstract][Full Text] [Related]
7. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
[TBL] [Abstract][Full Text] [Related]
8. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.
Kitano K; Kobayashi H; Hanamura M; Furuta K; Ueno M; Rokuhara A; Tanaka E; Umemura T; Kiyosawa K
Eur J Haematol; 2006 Sep; 77(3):255-8. PubMed ID: 16923112
[TBL] [Abstract][Full Text] [Related]
9. Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapy.
Zhang JM; Wang XY; Huang YX; Yin YK; Guan S; Xu Y; Roggendorf M; Lu M
J Med Virol; 2006 Mar; 78(3):324-8. PubMed ID: 16419112
[TBL] [Abstract][Full Text] [Related]
10. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
Schmidt LE; Tofteng F; Strauss GI; Larsen FS
Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
[TBL] [Abstract][Full Text] [Related]
11. Pediatric acute liver failure with molecular adsorbent recirculating system treatment.
Novelli G; Rossi M; Morabito V; Pugliese F; Ruberto F; Perrella SM; Novelli S; Spoletini G; Ferretti G; Mennini G; Berloco PB
Transplant Proc; 2008; 40(6):1921-4. PubMed ID: 18675090
[TBL] [Abstract][Full Text] [Related]
12. Antiviral therapy for hepatitis B virus associated hepatic failure.
Wang YM; Tang YZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):17-24. PubMed ID: 19208509
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy.
Camus C; Lavoué S; Gacouin A; Compagnon P; Boudjéma K; Jacquelinet C; Thomas R; Le Tulzo Y
Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480
[TBL] [Abstract][Full Text] [Related]
14. [Lamivudine administration prevents fulminant hepatic failure in patients with severe chronic hepatitis B].
Cui JJ; Zhou BP; Dai W
Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):261-3. PubMed ID: 16635293
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of fulminant hepatitis B during pregnancy.
Potthoff A; Rifai K; Wedemeyer H; Deterding K; Manns M; Strassburg C
Z Gastroenterol; 2009 Jul; 47(7):667-70. PubMed ID: 19606409
[TBL] [Abstract][Full Text] [Related]
16. Antiviral treatment of chronic hepatitis B with lamivudine in pediatric renal transplantation.
Kranz B; Vester U; Bonzel KE; Paul A; Gerken G; Hoyer PF
Pediatr Transplant; 2006 May; 10(3):384-9. PubMed ID: 16677367
[TBL] [Abstract][Full Text] [Related]
17. Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B.
Chan HL; Wong VW; Hui AY; Tsang SW; Chan JL; Chan HY; Wong GL; Sung JJ
Antivir Ther; 2006; 11(4):465-71. PubMed ID: 16856620
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of hepatitis B virus infection with Lamivudine after heart transplantation.
Wang SS; Chou NK; Chi NH; Hsu RB; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Lai MY; Chu SH
Transplant Proc; 2006 Sep; 38(7):2138-40. PubMed ID: 16980024
[TBL] [Abstract][Full Text] [Related]
19. Changes in serological markers of hepatitis B virus after renal transplantation.
Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
[TBL] [Abstract][Full Text] [Related]
20. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
Uhm JE; Kim K; Lim TK; Park BB; Park S; Hong YS; Lee SC; Hwang IG; Koh KC; Lee MH; Ahn JS; Kim WS; Jung CW; Kang WK
Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
